Cotización Ironwood Pharmaceuticals - IRWD

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

3.56

Postura de Compra

3.25

Postura de Venta

3.60

Volume Operado de la Acción

2,859,430

3.48 Rango del Día 3.75

3.06 Rango de 52 semanas 15.70

Capitalización de Mercado [m]

569.701M

Precio Anterior

3.69

Precio de Apertura

3.63

Hora

3.59

Última hora de negociación

Volumen financiero

US$ 10,212,146

Precio Promedio Ponderado

3.5714

Volumen promedio (3 m)

1,552,906

Acciones en circulación

160,028,388

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.57

Beneficio por acción (BPA)

-6.26

turnover

442.74M

Beneficio neto

-1B

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.ironwoodpharma.com

Sede

Wilmington, Delaware, USA

Fundado

Ironwood Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IRWD. The last closing price for Ironwood Pharmaceuticals was US$3.69. Over the last year, Ironwood Pharmaceuticals shares have traded in a share price range of US$ 3.06 to US$ 15.70.

Ironwood Pharmaceuticals currently has 160,028,388 shares in issue. The market capitalisation of Ironwood Pharmaceuticals is US$590.50 million. Ironwood Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.57.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.015	-0.41958041958	3.575	4.05	3.06	2162512	3.65280292	CS
4	-0.76	-17.5925925926	4.32	4.41	3.06	1763341	3.63494806	CS
12	-0.99	-21.7582417582	4.55	5.05	3.06	1552906	4.05142601	CS
26	-2.84	-44.375	6.4	7.105	3.06	1880616	4.92879301	CS
52	-6.71	-65.3359298929	10.27	15.7	3.06	2796493	8.30032964	CS
156	-7.45	-67.6657584015	11.01	15.7	3.06	2526101	9.95897618	CS
260	-8.82	-71.2439418417	12.38	15.7	3.06	2279699	10.38441816	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
SHOTWSafety Shot Inc	US$ 0.25 (79.21%)	28.01k
PALIPalisade Bio Inc	US$ 2.36 (68.57%)	67.27M
LAESSEALSQ Corporation	US$ 1.8401 (60.01%)	250.65M
HIMXHimax Technologies Inc	US$ 9.73 (45.22%)	20.05M
TRVITrevi Therapeutics Inc	US$ 3.60 (44.58%)	63.49M
SPGCSacks Parente Golf Inc	US$ 0.3621 (-74.14%)	29.71M
KROSKeros Therapeutics Inc	US$ 18.40 (-73.20%)	14.65M
TFFPTFF Pharmaceuticals Inc	US$ 0.0657 (-59.62%)	13.29M
SFHGSamfine Creation Holdings Group Ltd	US$ 1.27 (-58.36%)	7.38M
APVOAptevo Therapeutics Inc	US$ 5.60 (-44.06%)	6.49M
GOEVCanoo Inc	US$ 0.1737 (33.62%)	970.8M
LAESSEALSQ Corporation	US$ 1.8401 (60.01%)	256.79M
NVDANVIDIA Corporation	US$ 137.34 (-1.41%)	159.23M
RGTIRigetti Computing Inc	US$ 5.9591 (-19.25%)	158.72M
CDTConduit Pharmaceuticals Inc	US$ 0.0798 (-9.63%)	119.28M